China animal vaccine industry report, 2010 2011

China Animal Vaccine Industry Report, 2010-2011 August 2011

[object Object],[object Object],[object Object],[object Object],Please visit our website to order this report and find more information about other titles at www.researchinchina.com Related Products China Human Vaccine Industry Report, 2010-2011 China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010 China Interventional Cardiovascular Device Industry Report, 2010 China Insulin Industry Report, 2010 China Medical Imaging Device Industry Report, 2010 China Medical Monitor Industry Report, 2010

[object Object],[object Object],[object Object],Abstract China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the increase of the state investment in animal epidemic funds, the expansion of compulsory immunization against animal epidemics and immunization scope as well as the strengthening of China livestock breeding industry standardization, China animal vaccine industry is expected to continue to maintain a relatively high growth momentum in future. Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few enterprises. CAHIC, Yebio QD, Guangdong Dahuanong Animal Health Products, Tecon and Chengdu Tech-Bank are representatives of China animal vaccine industry, accounting for a market share of 37.4%. Sales of these companies mainly come from the government procurement of compulsory vaccines, wherein, the revenue from government compulsory vaccines accounted for 88% of the total animal vaccine revenue of CAHIC in 2010.

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],According to China’s compulsory immunization plan against animal epidemics in recent three years, China not only expands the application scope of the existing animal immunization products, but also attaches great importance to the upgrading of animal vaccine products at the same time. The applications of high-performance passage cell-derived vaccine, synthesis peptide vaccine, etc. are gradually being expanded, e.g., Classical Swine Fever Vaccine, Live (Cell Line Origin) expanded its application coverage from eight provinces in 2010 to sixteen provinces in 2011. However, due to the high requirements on technology and equipment from passage cell-derived vaccine, synthesis peptide vaccine, etc., there are limited manufacturers available right now. Although CAHIC, Tecon, etc all start their layout in the field of Classical Swine Fever Vaccine, Live (Cell Line Origin), Guangdong Winsun Bio-pharmaceutical is still the major supplier in present market. Tecon, Shanghai Shenlian, CAHIC, etc involve in production and sales of synthesis peptide vaccine, but CAHIC produces synthesis peptide vaccine by purchasing antigen from Shanghai Shenlian.

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1. Overview of Animal Vaccine 1.1 Definition & Classification of Animal Vaccines 1.2 Definition & Classification of Animal Biological Products 1.3 Industry Chain 2. Operating Environment for Animal Vaccine Industry 2.1 Macro Environment 2.2 Policy Environment 2.3 Social Environment 2.4 International Environment 2.4.1 Market Scale 2.5 Overview of Vaccine Market 3. Development of Animal Vaccine Industry in China 3.1 Overview 3.2 Market Scale 3.3 Supply & Demand 3.4 Market Competition 3.5 Import and Export 3.5.1 Export 3.5.2 Import 3.6 Development Prospect 4. Animal Vaccine Market Segments in China 4.1 Swine Vaccines 4.1.1 Classical Swine Fever Vaccine 4.1.2 Pig Foot and Mouth Disease Vaccine 4.1.3 PRRS Vaccine Table of contents 5.5 Shenghua Biok 5.5.1 Profile 5.5.2 Operation 5.5.3 Yebio QD 5.6 Huasun Group 5.6.1 Profile 5.6.2 Operation 5.6.3 Sichuan Huasun 5.7 Harbin Pharmaceutical Group 5.7.1 Profile 5.7.2 Status Quo & Prospect of Animal Vaccine Business 5.8 Tianjin Ringpu Bio-technology 5.8.1 Profile 5.8.2 Operation 5.8.3 Status Quo & Prospect of Animal Vaccine Business 5.9 Guangdong Dahuanong Animal Health Products 5.9.1 Profile 5.9.2 Operation 5.9.3 Status Quo & Prospect of Animal Vaccine Business 5.10 Foreign Enterprises in China 5.10.1 Merial 5.10.2 Boehringer-Ingelheim 5.10.3 Bayer 5.10.4 Novartis 5.10.5 Pfizer

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Selected Charts

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Selected Charts

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Selected Charts

[object Object],[object Object],[object Object],[object Object],[object Object],Choose type of format Hard copy …………………………2100 USD PDF (Single user license) ………......2000 USD PDF (Enterprisewide license)….. ......3100 USD ※ Reports will be dispatched immediately once full payment has been received. Payment may be made by wire transfer or credit card via Paypal. Room 1008, A2, Tower A, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080 Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● [email_address] How to Buy Party A: Name: Address: Contact Person: Tel E-mail: Fax Party B: Name: Beijing Waterwood Technologies Co., Ltd (ResearchInChina) Address: Room 1008, A2, Tower A, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080 Contact Person: Liao Yan Phone: 86-10-82600828 E-mail: [email_address] Fax: 86-10-82601570 Bank details: Beneficial Name: Beijing Waterwood Technologies Co., Ltd Bank Name: Bank of Communications, Beijing Branch Bank Address: NO.1 jinxiyuan shijicheng,Landianchang,Haidian District,Beijing Bank Account No #: 110060668012015061217 Routing No # : 332906 Bank SWIFT Code: COMMCNSHBJG Title Format Cost Total

China animal vaccine industry report, 2010 2011

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Mehr von ResearchInChina

Mehr von ResearchInChina (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

China animal vaccine industry report, 2010 2011